L-methymalonyl-CoA mutase converts L-methymalonyl-CoA to succinyl-CoA, which is essential for the metabolism of protein and fat
Following the loading phase, maintenance injections are given every two to three months for life, as pernicious anaemia is a chronic condition requiring ongoing treatment
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist
Clear or very pale blue might mean insufficient copper binding or extremely dilute concentrations
The MCV value on the CBC supports the clinical picture but doesn't drive code selection independently
The active ingredient, orforglipron, is a different molecule from semaglutide or tirzepatide